Pharmafile Logo
Pharmafocus logo
Advanced Search

Chiesi Farmaceutici

Showing 1 posts of 1 posts found.

Study into treatment for rare condition in premature infants launches globally

June 9, 2025
Research and Development Chiesi Farmaceutici, Elgan Pharma, Gastrointestinal tract, Paediatrics, clinical trial, intestinal malabsorption, premature infant health

Elgan Pharma, specialising in neonatology, and Italy-based biopharma, Chiesi Farmaceutici, have announced the dosing of the first participating infants in …

News
The Gateway to Local Adoption Series

Latest content

Product value to pathway impact: What the CVD Modern Service Framework means for pharma

August 9, 2026

Functional lung imaging offers new possibilities for respiratory care

August 9, 2026

Five Facts about cardiovascular disease

August 9, 2026

Data integrity: the keystone for AI adoption, patient safety and organisational reputation

August 9, 2026

Artificial hearts: a century of innovation

August 9, 2026